Capricor, Inc.

Capricor Therapeutics, Inc. is a biotechnology company specializing in cell and exosome-based therapies, with a focus on treating rare diseases such as Duchenne muscular dystrophy. Their lead product, Deramiocel, is in late-stage development, and they are advancing exosome technology for delivering therapeutic nucleic acids and proteins.